Literature DB >> 30889044

Selenoprotein P in Myocardial Infarction With Cardiogenic Shock.

Petra Büttner1, Danilo Obradovic1, Sebastian Wunderlich1, Hans-Josef Feistritzer1, Erik Holzwirth1, Philipp Lauten1, Georg Fuernau2, Suzanne de Waha-Thiele2, Steffen Desch1, Holger Thiele1.   

Abstract

BACKGROUND: Reperfusion strategies in acute myocardial infarction (AMI) may result in ischemia reperfusion injury characterized by increased oxidative stress, inflammation, and ultimately death of myocardial tissue which may be of particular importance in infarct-related cardiogenic shock (CS). Many anti-oxidative and immune regulatory processes depend on selenium which in large proportions is bound to circulating selenoprotein P (SelP). Individual SelP patterns may therefore be associated with inflammatory response and possibly mortality in patients with CS post AMI.
METHODS: In the randomized Intra-Aortic Balloon Pump in cardiogenic Shock II (IABP-SHOCK II)-trial, 600 patients with CS complicating AMI were assigned to therapy with or without IABP. In a predefined biomarker substudy of 147 patients, we analyzed SelP levels 1 and 3 days following randomization. Samples were compared with healthy controls and associations with the unspecific inflammatory marker C-reactive protein (CRP) were analyzed.
RESULTS: Compared with controls SelP levels in patients with infarct-related CS were markedly higher (2.7-fold at day 1 and 5.7-fold at day 3 following AMI, all P < 0.001). Thirty-day mortality was significantly higher in patients with SelP levels above the 75th percentile at day 3 following AMI (26% vs. 46%, P = 0.045). SelP was significantly proportionally correlated with CRP 1 (R = 0.762, P < 0.0001) and 3 days (R = 0.777 P < 0.0001) following AMI.
CONCLUSION: SelP levels are significantly increased post AMI with CS. Higher SelP levels are associated with increased CRP levels indicative for inflammatory processes. Future studies should focus on the characterization of SelP profiles following AMI and the identification of pathomechanisms affected by SelP.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30889044     DOI: 10.1097/SHK.0000000000001342

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

Review 1.  Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins.

Authors:  Carmine Rocca; Teresa Pasqua; Loubna Boukhzar; Youssef Anouar; Tommaso Angelone
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

2.  Increases in Hepatokine Selenoprotein P Levels Are Associated With Hepatic Hypoperfusion and Predict Adverse Prognosis in Patients With Heart Failure.

Authors:  Ryohei Takeishi; Tomofumi Misaka; Yasuhiro Ichijo; Shinji Ishibashi; Mitsuko Matsuda; Yukio Yamadera; Himika Ohara; Yukiko Sugawara; Yu Hotsuki; Koichiro Watanabe; Fumiya Anzai; Yu Sato; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Kazuhiko Nakazato; Akiomi Yoshihisa; Yasuchika Takeishi
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

Review 3.  The Impact of Selenium Deficiency on Cardiovascular Function.

Authors:  Briana K Shimada; Naghum Alfulaij; Lucia A Seale
Journal:  Int J Mol Sci       Date:  2021-10-02       Impact factor: 5.923

4.  The Gut Microbiome, Seleno-Compounds, and Acute Myocardial Infarction.

Authors:  Fu-Chun Chiu; Chin-Feng Tsai; Pang-Shuo Huang; Ching-Yu Shih; Mong-Hsun Tsai; Juey-Jen Hwang; Yi-Chih Wang; Eric Y Chuang; Chia-Ti Tsai; Sheng-Nan Chang
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

5.  Long non-coding RNA LUCAT1 inhibits myocardial oxidative stress and apoptosis after myocardial infarction via targeting microRNA-181a-5p.

Authors:  Shi-Hui Xiao; Ying Wang; Xuecai Cao; Zhe Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  Characterization and Quantification of Selenoprotein P: Challenges to Mass Spectrometry.

Authors:  Jérémy Lamarche; Luisa Ronga; Joanna Szpunar; Ryszard Lobinski
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.